sars-cov-2 equine immunoglobulin
Animal productexperimentalCOVID-19
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Sep 6, 2020 (NCT04610502)
Timeline
2020s
- Jan 1, 2020
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- SARS-CoV-2Immunity, passive
SARS-CoV-2 immunity, passive
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04610502 | Phase 2 | Sep 6, 2020 | Caja Costarricense de Seguro Social, Government of Costa Rica, Universidad de Costa Rica |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Caja Costarricense de Seguro Social | Academic/Hospital | 1 | 1 | 1 | 2020 |
| Government of Costa Rica | Government | 1 | 0 | 1 | 2020 |
| Universidad de Costa Rica | Academic/Hospital | 1 | 0 | 1 | 2020 |
3 organizations
Page 1 / 1